COVID Vaccine Sales and Company Strategy

This chapter discusses a German biotechnology company's declining stock price due to declining COVID vaccine sales, but highlights the value in their oncology pipeline. The speakers contemplate what to do with a company's cash generated from COVID-related trucks, discussing investment in pipeline, dividends, or acquisition. Additionally, Chevron's performance as an energy company, challenges they face, and the potential of higher oil prices are discussed.